The effects of sildenafil on human sperm function in healthy volunteers
- 1 February 2002
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 53 (s1) , 53S-60S
- https://doi.org/10.1046/j.0306-5251.2001.00033.x
Abstract
Aims This double‐blind, randomized, four‐period, two‐way crossover study was conducted to evaluate the acute effects of oral sildenafil (100‐mg single dose) on sperm motility, count, density, morphology and vitality as well as ejaculate volume and viscosity in healthy male subjects. The concentrations of sildenafil and its primary circulating metabolite UK‐103,320 were measured in ejaculate and compared with those in plasma. The study also included assessments of safety and tolerability.Methods A total of 17 healthy male volunteers aged 19–34 years were randomized to receive a single 100‐mg dose of sildenafil for two periods and a single dose of placebo for two periods, with each period separated by a minimum of 5–7 days. Sperm and ejaculate properties were evaluated from semen samples taken at screening and 1.5 h after dose. An additional semen sample was collected 4 h after dose, and drug and metabolite concentrations were measured in this sample and the sample taken 1.5 h after dose for comparison with plasma concentrations. Blood samples were collected before each dose and 0.25, 0.5, 1, 2, 3, 4 and 6 h after dose for measurement of sildenafil and metabolite concentrations.Results Sildenafil had no statistically significant effect on sperm motility, count or density; the percentage of abnormal sperm forms; or the percentage of living sperm. It also did not affect ejaculate volume or viscosity. All measures were within normal ranges. Sildenafil distributed into the semen rapidly, resulting in significant correlations between concentrations of sildenafil in the semen and total (R2=0.588) or free (R2=0.454) plasma concentrations (P−4% of the administered dose at 1.5 h). Sildenafil was well tolerated; no patient withdrew from the study due to adverse events attributed to sildenafil.Conclusions These results indicate that a single 100‐mg oral dose of sildenafil does not have an adverse effect on sperm function or ejaculate quality.Keywords
This publication has 27 references indexed in Scilit:
- The use of sildenafil citrate for treatment of male infertility in males with erectile dysfunctionPublished by Wolters Kluwer Health ,2000
- Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1998
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMESJournal of Urology, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Drugs in SemenClinical Pharmacokinetics, 1994
- Sperm quality assessed by flow cytometry and accessory sex gland function in spinal cord injured men after repeated vibration-induced ejaculationSpinal Cord, 1993
- Relationship between sperm quality and chromatin condensation measured by sperm DNA fluorescence using flow cytometryInternational Journal of Andrology, 1992
- Sperm quality in men with chronicabacterial prostatovesiculitis verified by rectal ultrasonographyUrology, 1991
- Pentoxifylline stimulates human sperm motility both in vitro and after oral therapy.British Journal of Clinical Pharmacology, 1991
- Stability of sperm characteristics in men with disturbances in sperm qualityInternational Journal of Andrology, 1989